Other studies have also shown that treating primary human skin KCs with TNF-α or TGF-β induces mesenchymal morphological characteristics, similar to those we observed in our CytoMix-treated KCs, and is associated with increased VIM expression at both the gene and protein levels [33]. Here, VIM is linked to dry eye syndrome.